All data are based on the daily closing price as of March 28, 2025
a
Alfresa Holdings
2784.TSE
14.26 USD
-0.27
-1.86%
Overview
Last close
14.26 usd
Market cap
2.67B usd
52 week high
17.00 usd
52 week low
13.01 usd
Target price
15.33 usd
Valuation
P/E
13.145
Forward P/E
N/A
Price/Sales
0.1327
Price/Book Value
0.7926
Enterprise Value
1.47B usd
EV/Revenue
0.075
EV/EBITDA
4.3339
Key financials
Revenue TTM
19.27B usd
Gross Profit TTM
1.28B usd
EBITDA TTM
345.01M usd
Earnings per Share
1.13 usd
Dividend
0.21 usd
Total assets
10.18B usd
Net debt
-1.09B usd
About
Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is involved in the ethical pharmaceuticals wholesaling business that offers diagnostic reagents and medical devices/equipment to hospitals, clinics, and dispensing pharmacies. The company also engages in self-medication products wholesaling business that offers over-the-counter drugs, including health foods, supplements, and other products to drug stores and pharmacies. In addition, it manufactures and markets active pharmaceutical ingredients, pharmaceuticals, diagnostic reagents, and medical devices, as well as undertakes contract manufacturing of pharmaceuticals. Further, the company's medical-related business includes its dispensing pharmacy and other medical-related businesses. The company was incorporated in 2003 and is based in Tokyo, Japan.